RxDoctor Payments DataLook up a doctor →

Ryan Hornung

Nurse Practitioner · Harrisburg, PANPI 1497153985

Payments from drug & device makers

$17,510in general payments, 2019–2025

Across 1,027 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • AstraZeneca$2K
  • GSK$1K
  • Boehringer Ingelheim$1K
  • Lilly USA, LLC$866
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$17,495100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie126$2,091
Novo Nordisk125$1,991
AstraZeneca81$1,964
GSK118$1,475
Boehringer Ingelheim81$1,446
Lilly USA, LLC46$866
Amgen47$824
Pfizer62$690
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC44$495
Amarin Pharma, Inc.27$439
Johnson & Johnson20$332
Dexcom, Inc.13$290
Axsome Therapeutics, Inc.14$289
Sanofi Pasteur Inc.12$286
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)15$274
Exact Sciences13$256
E.r. Squibb & Sons, L.L.C.13$251
Esperion Therapeutics, Inc.8$243
Biohaven Pharmaceutical Holding Company Ltd.16$218
Otsuka America Pharmaceutical, Inc.10$204
Novartis9$195
Abbott8$166
Eisai Inc.6$159
Takeda Pharmaceuticals U.S.A., Inc.9$150
Teva Pharmaceuticals USA, Inc.8$149
Nestle Healthcare Nutrition Inc.9$128
Astellas Pharma US Inc6$122
Mylan Specialty L.p.4$109
Aimmune Therapeutics, Inc.7$108
IBSA Pharma Inc.5$105
Merck6$98
Lundbeck LLC4$91
Vanda Pharmaceuticals Inc.3$83
Biohaven Pharmaceuticals, Inc.5$81
Sumitomo Pharma America, Inc.3$73
Phathom Pharmaceuticals, Inc.6$59
Biogen3$58
Halozyme Inc2$46
Kowa Pharmaceuticals America, Inc.3$44
Inspire Medical Systems, Inc.2$43
Cequr Corporation2$42
Bayer2$41
Ironwood Pharmaceuticals, Inc2$39
Xeris Pharmaceuticals, Inc.2$33
Harmony Biosciences LLC2$31
Idorsia Pharmaceuticals US Inc2$31
Radius Health, Inc.1$30
Viatris Specialty LLC1$29
Sanofi-aventis U.S. LLC2$27
Actelion Pharmaceuticals US, Inc.1$25
Regeneron Healthcare Solutions, Inc.1$21
Verona Pharma, Inc.1$21
Mannkind Corporation1$20
Cumberland Pharmaceuticals, Inc.1$19
Corium, LLC1$18
Neurelis, Inc.1$18
Shield Therapeutics Inc1$17
Almatica Pharma LLC1$16
OPKO Pharmaceuticals, LLC1$14
Intra-sana Laboratories1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,510 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.

See all nurse practitioner providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$43,907
Medicare patients
124
Services billed
714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$63,872
FarxigaDapagliflozin Propanediol83$63,626
TrulicityDulaglutide39$42,730
EliquisApixaban46$36,882
Nurtec OdtRimegepant Sulfate26$34,548
JardianceEmpagliflozin18$18,703
JanuviaSitagliptin Phosphate13$16,889
MounjaroTirzepatide14$14,300
VascepaIcosapent Ethyl21$12,715
RybelsusSemaglutide13$12,040
Repatha SureclickEvolocumab12$9,270
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$8,750
Stiolto RespimatTiotropium Br/Olodaterol Hcl18$7,943
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,817
Levothyroxine Sodium93$2,607

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,991$75,91366 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,964$72,37695 claims
PfizerEliquis, Nurtec Odt$690$71,43172 claims
Lilly USA, LLCTrulicity, Mounjaro$866$57,03053 claims
Boehringer IngelheimJardiance, Stiolto Respimat$1,446$26,64636 claims
MerckJanuvia$98$16,88913 claims
GSKTrelegy Ellipta$1,475$7,81712 claims
AbbVieSynthroid$2,091$1,59117 claims
Almatica Pharma LLCSertraline Hcl$16$89754 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.

Other nurse practitioner in Harrisburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →